Idexx Laboratories Profit Margin

The latest profit margin for IDXX is 25.03% as of June 2026. That compares with 24.41% in the prior-year period — up 2.5% year over year. That is above the Healthcare sector average of 13.89%. Investors often review this figure alongside Idexx Laboratories's historical trend and sector peers before judging valuation or financial health.

Over the past year, IDXX's profit margin moved from 24.41% to 25.03% — a 2.5% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Idexx Laboratories's valuation or profitability profile.

Against Healthcare companies, IDXX currently prints 25.03% for profit margin, while the sector average sits near 13.89%. That is roughly 80.3% above the sector mean. Large gaps often invite a closer look at Idexx Laboratories's growth, margins, and balance sheet.

Profit Margin shows how effectively Idexx Laboratories converts resources into returns. At 25.03%, IDXX may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 24.41% in the prior-year period — up 2.5% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting IDXX's profit margin (25.03%), review year-over-year change from 24.41%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.